These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 32557351

  • 1. Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)-development and in-vitro efficacy.
    Elbatanony RS, Parvathaneni V, Kulkarni NS, Shukla SK, Chauhan G, Kunda NK, Gupta V.
    Drug Deliv Transl Res; 2021 Jun; 11(3):927-943. PubMed ID: 32557351
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC).
    Parvathaneni V, Goyal M, Kulkarni NS, Shukla SK, Gupta V.
    Pharm Res; 2020 Jun 08; 37(7):123. PubMed ID: 32514688
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer.
    Wang X, Parvathaneni V, Shukla SK, Kulkarni NS, Muth A, Kunda NK, Gupta V.
    Int J Biol Macromol; 2020 Dec 01; 164():638-650. PubMed ID: 32693132
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.
    Vaidya B, Parvathaneni V, Kulkarni NS, Shukla SK, Damon JK, Sarode A, Kanabar D, Garcia JV, Mitragotri S, Muth A, Gupta V.
    Int J Biol Macromol; 2019 Feb 01; 122():338-347. PubMed ID: 30401652
    [Abstract] [Full Text] [Related]

  • 11. Inhaled delivery of cetuximab-conjugated immunoliposomes loaded with afatinib: A promising strategy for enhanced non-small cell lung cancer treatment.
    Liu S, Chen D, Zhu X, Wang X, Li X, Du Y, Zhang P, Tian J, Song Y.
    Drug Deliv Transl Res; 2024 Nov 01; 14(11):3147-3162. PubMed ID: 38381317
    [Abstract] [Full Text] [Related]

  • 12. Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics.
    Vaidya B, Kulkarni NS, Shukla SK, Parvathaneni V, Chauhan G, Damon JK, Sarode A, Garcia JV, Kunda N, Mitragotri S, Gupta V.
    Int J Pharm; 2020 Mar 15; 577():118995. PubMed ID: 31935471
    [Abstract] [Full Text] [Related]

  • 13. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
    Jyoti K, Kaur K, Pandey RS, Jain UK, Chandra R, Madan J.
    J Colloid Interface Sci; 2015 May 01; 445():219-230. PubMed ID: 25622047
    [Abstract] [Full Text] [Related]

  • 14. Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment.
    Yang Y, Liu Q, Cao L, Sun W, Gu X, Liu B, Xiao N, Teng F, Li X, Chen M, Yu W, Lin H, Xu G.
    BMC Pulm Med; 2021 May 19; 21(1):172. PubMed ID: 34011336
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oral inhalation of dacomitinib nanocarriers as a therapeutic strategy for non-small cell lung cancer.
    Rongala DS, Patil SM, Kunda NK.
    Nanomedicine (Lond); 2024 May 19; 19(18-20):1601-1613. PubMed ID: 39073842
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
    Mandal B, Mittal NK, Balabathula P, Thoma LA, Wood GC.
    Eur J Pharm Sci; 2016 Jan 01; 81():162-71. PubMed ID: 26517962
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.